• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. - CRM FACILITY ISOLINE; DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. - CRM FACILITY ISOLINE; DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER Back to Search Results
Model Number ISOLINE 2CT6
Device Problems Over-Sensing (1438); Inappropriate/Inadequate Shock/Stimulation (1574); Low impedance (2285)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/05/2020
Event Type  Injury  
Event Description
The subject rv lead was implanted on (b)(6) 2010.In the follow up performed on (b)(6) 2020 no anomaly was identified.On (b)(6) 2020 an inappropriate shock occurred while the patient was cutting his toenail, the physician interrogated the device and confirmed this event.To avoid another inappropriate shock, vf zone continuous cycle was changed from 6 to 20 and the ventricular sensitivity was changed from 0.4mv to 0.8 mv.On (b)(6) 2020 another device check was performed.The ventricular impedance was below 200o while intermittent oversensing was found.Atrial sensitivity, both atrial and ventricular thresholds were normal.No new episode had been recorded since the latest check performed on the previous day.The patient was stable but was hospitalized in order to have inspection for the bloodstream of subclavian vein and superior vena cava.A re-intervention to add a new lead is scheduled on (b)(6) 2020.
 
Event Description
The subject rv lead was implanted on (b)(6) 2010.In the follow up performed on (b)(6) 2020 no anomaly was identified.On (b)(6) 2020 an inappropriate shock occurred while the patient was cutting his toenail, the physician interrogated the device and confirmed this event.To avoid another inappropriate shock, vf zone continuous cycle was changed from 6 to 20 and the ventricular sensitivity was changed from 0.4mv to 0.8 mv.On (b)(6) 2020 another device check was performed.The ventricular impedance was below 200o while intermittent oversensing was found.Atrial sensitivity, both atrial and ventricular thresholds were normal.No new episode had been recorded since the latest check performed on the previous day.The patient was stable but was hospitalized in order to have inspection for the bloodstream of subclavian vein and superior vena cava.On (b)(6) 2020, a re-intervention was performed.The subject lead was abandoned in the patient's body and another lead was implanted.
 
Manufacturer Narrative
B5 updated.
 
Event Description
The subject rv lead was implanted on (b)(6) 2010.In the follow up performed on (b)(6) 2020 no anomaly was identified.On (b)(6) 2020 an inappropriate shock occurred while the patient was cutting his toenail, the physician interrogated the device and confirmed this event.To avoid another inappropriate shock, vf zone continuous cycle was changed from 6 to 20 and the ventricular sensitivity was changed from 0.4mv to 0.8 mv.On (b)(6) 2020 another device check was performed.The ventricular impedance was below 2000 while intermittent oversensing was found.Atrial sensitivity, both atrial and ventricular thresholds were normal.No new episode had been recorded since the latest check performed on the previous day.The patient was stable but was hospitalized in order to have inspection for the bloodstream of subclavian vein and superior vena cava.On (b)(6) 2020 a re-intervention was performed.The subject lead was abandoned in the patient's body and another lead was implanted.
 
Manufacturer Narrative
Please refer to the attached analysis report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISOLINE
Type of Device
DEFIBRILLATOR, IMPLANTABLE, DUAL-CHAMBER
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L. - CRM FACILITY
via crescentino s.n.
.
saluggia 13040
IT  13040
MDR Report Key10669631
MDR Text Key211047875
Report Number1000165971-2020-00640
Device Sequence Number1
Product Code MRM
Combination Product (y/n)N
PMA/PMN Number
P980049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 01/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/20/2012
Device Model NumberISOLINE 2CT6
Device Catalogue NumberISOLINE 2CT6
Device Lot Number2387
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date10/07/2020
Event Location Hospital
Initial Date Manufacturer Received 10/07/2020
Initial Date FDA Received10/13/2020
Supplement Dates Manufacturer Received10/21/2020
12/18/2020
Supplement Dates FDA Received11/13/2020
01/11/2021
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-0928-2013
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-